相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation
Meng Lou et al.
JOURNAL OF MEDICAL VIROLOGY (2023)
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs
Zezhong Liu et al.
CELL RESEARCH (2022)
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland et al.
CHEMICAL REVIEWS (2022)
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS-cGAMP-STING Pathway
Christopher Ritchie et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2022)
Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
Rahul Bhattacharjee et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
A kinase-cGAS cascade to synthesize a therapeutic STING activator
John A. McIntosh et al.
NATURE (2022)
Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity
Ying Gao et al.
CELL RESEARCH (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
Nisha B. Nagarsheth et al.
NATURE MEDICINE (2021)
Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response
Fan Shi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)
Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout
Shuai Zhen et al.
CANCER GENE THERAPY (2020)
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING
Xiaobo Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins
Irene Lo Cigno et al.
PATHOGENS (2020)
Old dogs, new trick: classic cancer therapies activate cGAS
Seoyun Yum et al.
CELL RESEARCH (2020)
The Age of Cyclic Dinucleotide Vaccine Adjuvants
Himanshu Gogoi et al.
VACCINES (2020)
An orally available non-nucleotide STING agonist with antitumor activity
Bo-Sheng Pan et al.
SCIENCE (2020)
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic
Emily N. Chin et al.
SCIENCE (2020)
The interactions between cGAS-STING pathway and pathogens
Zhangliang Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Structural basis of STING binding with and phosphorylation by TBK1
Conggang Zhang et al.
NATURE (2019)
Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy
M. Vonsky et al.
BIOCHEMISTRY-MOSCOW (2019)
STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability
Diana Rose E. Ranoa et al.
CANCER RESEARCH (2019)
HPV: Molecular pathways and targets
Shilpi Gupta et al.
CURRENT PROBLEMS IN CANCER (2018)
E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study
Murali Aarthy et al.
GENE (2018)
STING Signaling Promotes Apoptosis, Necrosis, and Cell Death: An Overview and Update
Song Liu et al.
MEDIATORS OF INFLAMMATION (2018)
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu et al.
NATURE (2018)
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
Isabelle Melki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Mitotic progression following DNA damage enables pattern recognition within micronuclei
Shane M. Harding et al.
NATURE (2017)
The cGAS-STING Defense Pathway and Its Counteraction by Viruses
Zhe Ma et al.
CELL HOST & MICROBE (2016)
Stimulator of interferon genes (STING): A new chapter in virus-associated cancer research. Lessons from wild-derived mouse models of innate immunity
Alexander Poltorak et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Current state in the development of candidate therapeutic HPV vaccines
Andrew Yang et al.
EXPERT REVIEW OF VACCINES (2016)
DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation
Juan Yi et al.
NUCLEIC ACIDS RESEARCH (2015)
DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway
Laura Lau et al.
SCIENCE (2015)
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Zheng Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
Activated STING in a Vascular and Pulmonary Syndrome
Y. Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Structure and Ubiquitination-Dependent Activation of TANK-Binding Kinase 1
Daqi Tu et al.
CELL REPORTS (2013)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Papillomaviruses and cancer: From basic studies to clinical application
H zur Hausen
NATURE REVIEWS CANCER (2002)
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
K Münger et al.
ONCOGENE (2001)
Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle
P Massimi et al.
VIROLOGY (2000)
分享论文
